|
Market Closed -
Nasdaq
16:00:00 2026-06-15 EDT
|
5-day change | 1st Jan Change | ||
| 23.50 USD | +0.09% |
|
-.--% | +159.10% |
| 06-16 | Assertio Holdings Completes Merger With Zydus Lifesciences | MT |
| 06-16 | Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026 | CI |
| Market Cap | 152M 130M 122M 111M 209M 14.53B 212M 1.44B 561M 7.3B 570M 558M 24.14B | P/E 2027 * |
-
| P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 129M 110M 103M 94.43M 177M 12.31B 180M 1.22B 475M 6.19B 483M 473M 20.46B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
99.05% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Assertio Holdings
| 1 day | +0.09% | ||
| 3 months | +0.56% | ||
| 6 months | +98.48% | ||
| Current year | +159.10% |
| Current year | 9.11 |  | 23.5 |
| 1 year | 8.61 | | 23.5 |
| 3 years | 7.71 | | 51.6 |
| 5 years | 7.71 | | 120.15 |
| 10 years | 7.71 | | 1,621.19 |
| Director | Title | Age | Since |
|---|---|---|---|
Ravi Yadavar
BRD | Director/Board Member | 26 | 2026-06-15 |
Punit Patel
BRD | Director/Board Member | - | 2026-06-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/5/26 | Free | Director | 4,851 | 0.0753% | ||
| 3/2/26 | Free | Chief Financial Officer | 39,932 | 0.6223% | ||
| 2/21/26 | Fiscal year | Chairperson | 2,852 | 0.0444% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.09% | -.--% | +103.46% | -54.52% | 152M | |
| +0.88% | +6.38% | +76.86% | +128.23% | 1,109B | |
| +1.07% | +3.80% | +51.03% | +61.48% | 644B | |
| +1.20% | +6.21% | +26.47% | +76.45% | 463B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 371B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 301B | |
| +1.26% | +4.54% | +2.20% | +14.84% | 256B | |
| +1.88% | +5.81% | +48.54% | +68.52% | 234B | |
| +1.59% | +0.87% | -12.95% | -51.91% | 205B | |
| +1.87% | +5.61% | +25.81% | +92.42% | 178B | |
| Average | +1.17% | +3.72% | +38.84% | +42.48% | 376.12B | |
| Weighted average by Cap. | +1.14% | +4.47% | +44.52% | +72.61% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 400K 343K 321K 293K 551K 38.27M 558K 3.79M 1.48M 19.23M 1.5M 1.47M 63.59M | - |
| Net Debt | - | - |
Employees
53
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ASRT Stock
Select your edition
All financial news and data tailored to specific country editions
